Hypothesis: Age‑Dependent XCI Skewing in Vascular Endothelium Mediates Sex Differences in Arterial Stiffness

Core idea – With advancing age, random X‑chromosome inactivation (XX) undergoes progressive skewing that silences deleterious alleles while preserving protective X‑linked loci. This epigenetic tuning improves endothelial nitric‑oxide bioavailability and reduces oxidative stress, thereby lowering pulse‑wave velocity (PWV) in XX individuals relative to XY. In contrast, XY endothelium lacks this adaptive buffering, leading to earlier arterial stiffening [https://pmc.ncbi.nlm.nih.gov/articles/PMC4030514/].

Mechanistic extension – We propose that the skewing bias is driven by selective pressure on X‑linked regulators of mitochondrial ROS handling (e.g., G6PD, TXNIP) and on modifiers of the Nrf2‑ARE antioxidant pathway. As senescent endothelial cells accumulate, cells harboring a favorable inactive X survive preferentially, shifting the mosaic expression toward a phenotype with higher glutathione recycling and lower NADPH oxidase activity. This creates a feed‑forward loop: improved redox balance sustains eNOS coupling, further limiting ROS production and arterial collagen cross‑linking [https://www.intechopen.com/chapters/85824].

Testable predictions –

1. In aged mice (≥20 mo), single‑cell RNA‑seq of aortic endothelium will show a significant increase in the proportion of cells where the same X chromosome is inactivated across >60 % of the population, correlating with lower PWV and higher plasma nitrite/nitrate ratios [https://www.ahajournals.org/doi/10.1161/ATVBAHA.123.319833].
2. Pharmacological enforcement of XCI skewing (using Xist‑ antisense oligonucleotides to bias inactivation) in young XX mice will prematurely adopt the aged‑like endothelial expression signature and reduce PWV compared with scramble‑treated controls.
3. XY mice engineered to express a second, inactive X chromosome (via autosomal insertion of a XIST‑triggered silencer) will acquire endothelial mosaicism and exhibit delayed age‑related PWV rise, approaching XX levels [https://academic.oup.com/eurjpc/article/33/3/316/8113567].

Falsifiable outcomes – If longitudinal tracking reveals no age‑associated increase in XCI skewing, or if forced skewing fails to improve endothelial redox markers or PWV, the hypothesis is refuted. Likewise, if XY mice with an extra inactive X show no protective effect, the proposed mosaicism mechanism would be insufficient.

Experimental design –

• Cohorts: XX and XY mice, n=15 per group, sampled at 3, 12, 20 months.
• Assessments: PWV by Doppler, endothelial NO synthase coupling (DHE fluorescence), mitochondrial ROS (MitoSOX), single‑cell XCI status (RNA‑seq SNP‑allele counting).
• Interventions: Xist‑ASO delivery via tail‑vein liposomes; CRISPR‑knock‑in of XIST‑responsive silencer on autosome.

Broader implication – Demonstrating that the X chromosome operates as a dosage‑sensitive, epigenetically tunable longevity module would shift focus from hormonal explanations to chromosome‑wide regulatory dynamics, offering a new axis for sex‑specific interventions in vascular aging.